List of Tables
List of Figures
Oxford Immunotec Ltd Company Overview
Oxford Immunotec Ltd Company Snapshot
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd - Pipeline Analysis Overview
Oxford Immunotec Ltd - Key Facts
Oxford Immunotec Ltd - Major Products and Services
Oxford Immunotec Ltd Pipeline Products by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Pipeline Products Overview
B Cell ELISPOT Assay
B Cell ELISPOT Assay Product Overview
Diagnostic Test - Autoimmune And Inflammatory Disease
Diagnostic Test - Autoimmune And Inflammatory Disease Product Overview
Diagnostic Test - Chronic Infections
Diagnostic Test - Chronic Infections Product Overview
ELISPOT Tumor Assay
ELISPOT Tumor Assay Product Overview
I-O Monitoring Test
I-O Monitoring Test Product Overview
Metabovis Assay - Homocysteine
Metabovis Assay - Homocysteine Product Overview
Risk Stratification System - Kidney Transplantation
Risk Stratification System - Kidney Transplantation Product Overview
SpiroFind
SpiroFind Product Overview
Stratokine
Stratokine Product Overview
T-Cell Select
T-Cell Select Product Overview
T-SPOT.COVID Test
T-SPOT.COVID Test Product Overview
T-SPOT.COVID Test Clinical Trial
T-SPOT.ICA
T-SPOT.ICA Product Overview
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease Product Overview
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease Product Overview
Oxford Immunotec Ltd - Key Competitors
Oxford Immunotec Ltd - Key Employees
Oxford Immunotec Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Oxford Immunotec Ltd, Recent Developments
Oct 21, 2020: Oxford Immunotec Schedules Third Quarter 2020 Earnings Release and Conference Call for November 3, 2020
Aug 04, 2020: Oxford Immunotec reports second quarter 2020 financial results
Jul 21, 2020: Oxford Immunotec Schedules Second Quarter 2020 Earnings Release and Conference Call for August 4, 2020
Apr 29, 2020: Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020
Feb 24, 2020: Oxford Immunotec Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call for March 2, 2020
Feb 20, 2020: Oxford Immunotec announces new data on the utility of T-SPOT.CMV in kidney and stem cell transplant
Jan 23, 2020: Oxford Immunotec announces donation in support of Coronavirus testing efforts to help differentiate Tuberculosis from the new China virus
Nov 05, 2019: Oxford Immunotec reports third quarter 2019 financial results
Aug 06, 2019: Oxford Immunotec reports second quarter 2019 financial results
Jun 24, 2019: Oxford Immunotec appoints Patrick J. Balthrop, Sr. as Chairman
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd Pipeline Products by Equipment Type
Oxford Immunotec Ltd Pipeline Products by Indication
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd, Key Facts
Oxford Immunotec Ltd, Major Products and Services
Oxford Immunotec Ltd Number of Pipeline Products by Development Stage
Oxford Immunotec Ltd Pipeline Products Summary by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Ongoing Clinical Trials Summary
B Cell ELISPOT Assay - Product Status
B Cell ELISPOT Assay - Product Description
Diagnostic Test - Autoimmune And Inflammatory Disease - Product Status
Diagnostic Test - Autoimmune And Inflammatory Disease - Product Description
Diagnostic Test - Chronic Infections - Product Status
Diagnostic Test - Chronic Infections - Product Description
ELISPOT Tumor Assay - Product Status
ELISPOT Tumor Assay - Product Description
I-O Monitoring Test - Product Status
I-O Monitoring Test - Product Description
Metabovis Assay - Homocysteine - Product Status
Metabovis Assay - Homocysteine - Product Description
Risk Stratification System - Kidney Transplantation - Product Status
Risk Stratification System - Kidney Transplantation - Product Description
SpiroFind - Product Status
SpiroFind - Product Description
Stratokine - Product Status
Stratokine - Product Description
T-Cell Select - Product Status
T-Cell Select - Product Description
T-SPOT.COVID Test - Product Status
T-SPOT.COVID Test - Product Description
T-SPOT.COVID Test - A Phase I/II Randomized, Two Parts, Dose-finding Study to Evaluate the Safety, Tolerability and Immunogenicity of an Inactivated, Adjuvanted Sars-Cov-2 Virus Vaccine Candidate (VLA2001), Against Covid-19 in Healthy Subjects
T-SPOT.COVID Test - COVID Infection in Patients with Antibody Deficiency: COV-AD
T-SPOT.ICA - Product Status
T-SPOT.ICA - Product Description
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Description
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Description
Oxford Immunotec Ltd, Key Employees
Oxford Immunotec Ltd, Subsidiaries
Glossary

List of Figures
Oxford Immunotec Ltd Pipeline Products by Equipment Type
Oxford Immunotec Ltd Pipeline Products by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status

Companies Mentioned
- RUA Life Sciences Plc
- CME Medical UK Ltd
- Arcomedical Infusion Ltd